World Lifestyler
  • Art & Culture
    • Books & Literature
    • Cinema & Film
    • Design & Architecture
    • Exhibitions
    • Theatre
    • Music
  • Lifestyle
    • Fashion
    • Health & Fitness
    • Home & Living
    • Luxury Living
    • Car Reviews
    • Collectors
    • Luxury Cars
    • Planes
    • Private Jets
    • Yachts
  • Travel
    • Exclusives
    • Travel
      • Adventure & Tours
      • City Guides
      • Cruises
      • Holidays
      • Resorts & Spas
      • Reviews & Tips
    • Fashion Events
    • Festivals
    • Meetups
    • Outdoor Excursions
    • Road Trips
    • VIP Experiences
  • Food & Drink
    • Beers & Spirits
    • Chefs & Cooks
    • City Eating Guides
    • Fine Dining
    • Recipes
    • Restaurant Reviews
  • Tech
    • Audio
    • Gadgets
    • Gaming
    • Mobile
    • PCs
    • Reviews
    • VR/AR
    • Wearables
  • Art & Culture
    • Books & Literature
    • Cinema & Film
    • Design & Architecture
    • Exhibitions
    • Theatre
    • Music
  • Lifestyle
    • Fashion
    • Health & Fitness
    • Home & Living
    • Luxury Living
    • Car Reviews
    • Collectors
    • Luxury Cars
    • Planes
    • Private Jets
    • Yachts
  • Travel
    • Exclusives
    • Travel
      • Adventure & Tours
      • City Guides
      • Cruises
      • Holidays
      • Resorts & Spas
      • Reviews & Tips
    • Fashion Events
    • Festivals
    • Meetups
    • Outdoor Excursions
    • Road Trips
    • VIP Experiences
  • Food & Drink
    • Beers & Spirits
    • Chefs & Cooks
    • City Eating Guides
    • Fine Dining
    • Recipes
    • Restaurant Reviews
  • Tech
    • Audio
    • Gadgets
    • Gaming
    • Mobile
    • PCs
    • Reviews
    • VR/AR
    • Wearables
No Result
View All Result
World Lifestyler
No Result
View All Result
Home Lifestyle

Karelian Diamond Resources Plc – Reissue: Half-yearly results for the six months ended 30 November 2025

Cision PR Newswire by Cision PR Newswire
February 27, 2026
in Lifestyle
Reading Time: 91 mins read
0
Share on FacebookShare on Twitter





27 February 2026




Karelian.jpg




Karelian Diamond Resources plc


(“Karelian” or “the Company”)







Half-yearly results for the six months ended 30 November 2025





Please be advised that this announcement is a reissue of the one published at 7am this morning. The announcement is being reissued to facilitate display on third-party vendor screens. 




Karelian Diamond Resources plc (AIM: KDR), the diamond exploration company focused on Finland, announces its unaudited results for the six months ended 30 November 2025.  Details of these can be found below and a full copy of the interim results statement can be viewed on the Company’s website (www.kareliandiamondresources.com).





Highlights of the half-year period included:









  • In Northern Ireland t


    he Company holds a significant licence package covering over 1000 km


    ²


    and has established first mover advantage. It continues to advance its exploration programme for Nickel, Copper and Platinum Group Elements.













  • Exploration work also continued in the Kuhmo region in Finland with the Company focussing in particular on the geophysical Anomaly 5 as a priority. It lies up-ice of the green-diamond find.














  • At the Lahtojoki diamond deposit Karelian was, in June, granted a mining concession certificate and the focus of the Company’s efforts over the last number of months have been on advancing discussions with a view to securing appropriate strategic or partnership finance to progress development.













Brendan McMorrow, Chairman of Karelian Diamonds, stated:








“The Company is looking forward to progressing with the work programmes on its highly prospective Nickel, Copper and Platinum Group Element targets in Northern Ireland (including a tangible Copper target) and a clear work programme and strategy has been identified for its exploration assets in Finland.  The Board remains confident regarding the prospects for the Company”.






Further information:






Karelian Diamond Resources plc





Brendan McMorrow, Chairman / Maureen Jones, Managing Director





+353-1-479-6180






Allenby Capital Limited (Nomad)






Nick Athanas
/ Nick Harriss






+44-20-3328-5656







Albr Capital Limited


(Joint


Broker


)







Lucy Williams / Duncan Vasey







+44-20-
7469
-0930








CMC Markets


(Joint


Broker


)







Douglas Crippen







+44-20-
3003
–
8632







Lothbury Financial Services





Michael Padley





+44-20-3290-0707






Hall Communications





Don Hall





+353-1-660-9377






http://www.kareliandiamondresources.com






Chairman’s Statement






Dear Shareholder,






I have great pleasure in presenting the Company’s Half-Yearly Report and condensed Financial Statements for the period ended 30 November 2025.   The Company has been carefully progressing the potential of its assets during the period.





Northern Ireland – exploring Nickel, Copper, Platinum Group Elements




The Company holds a significant licence package covering over 1000 km2 in Northern Ireland where it has established first mover advantage and continues to advance its exploration programme exploring for Nickel, Copper and Platinum Group Elements.   Significant work was carried out by Dr Larry Hulbert, a geological consultant, first engaged in early 2024, who carried out an investigation of the licence areas and built a comprehensive database on them incorporating geology, geochemistry, geophysics, remote sensing, and base Geographic Information System (GIS) information including TELLUS data and gravity geophysical data.   



Dr Hulbert’s report confirmed significant potential for Nickel, Copper and Platinum Group Elements and recommended a follow up work programme.   The Company has been progressing with follow on work over the last six months including entering into an enterprise partnership with Trinity College Dublin on a work programme jointly funded by Research Ireland to be carried out on the Platinum Group Element potential of the Company’s licence areas in Ireland over the coming years.   In June 2025 the Company announced that it had identified the site of the historic Cappagh Copper Mine as a significant new target for investigation within the relevant licence area (KDR4).    This provides the Company with a tangible copper target in addition to the targets identified by Dr Hulbert’s report and we look forward to commencing a comprehensive exploration programme to unlock the full potential of this area.





Diamond exploration in Finland





While the market sentiment remains challenging from a diamond investment perspective, the Company is focussing its efforts on carefully progressing exploration work, positioning the Company well for a recovery in the retail sentiment towards natural stones.  The Company’s view is that in a global market segment for natural diamonds that is worth over US$29 billion annually, sustainably produced, traceable European diamonds will command a premium.  This premium would be supported by the potential for the Company’s assets to produce coloured diamonds.  




Exploration work in the Kuhmo region




Exploration work has continued in the Kuhmo region in Finland with the Company focussing in particular on the geophysical Anomaly 5 as a priority.  It lies up-ice of the green-diamond find and carries a near-source kimberlitic indicator minerals signature from glacial till sampling.   The Company has also been conducting a review of its exploration assets in the area which include the diamondiferous Seitaperä pipe (Finland’s largest, c.6.9 ha) and the Riihivaara kimberlite/olivine lamproite discovery. 




The Lahtojoki Diamond Deposit 




In June 2025 Karelian was granted a mining concession certificate by Tukes (the Finnish Mining Authority) which formally entitles the company to utilise the minerals within the mining concession area.   This was a very important milestone as it allows the Company to progress to the next stage of work on the mining concession area and accordingly mining rights related to the Lahtojoki mining concession.  The Lahtojoki diamond mining project comprises a mining concession covering 71 hectares (c. 176 acres) including a kimberlite pipe with a surface area of 1.6 hectares (c. 4 acres). The Company has been working with the relevant authorities to achieve the various milestones required for the granting of the mining concession.   In addition to this, the focus of the Company’s efforts over the last number of months on this project  has been on exploring possibilities in terms of securing appropriate strategic or partnership finance to progress development.




Financial Review




The loss after taxation for the half year ended 30 November 2025 was €165,591 (30 November 2024: loss of €121,186) and the net assets as at 30 November 2025 were €10,183,925 (30 November 2024: €9,993,699).   In June 2025 the Company raised £185,000 by way of a placing of new shares at an issue price of 0.75 pence per share and is currently considering a number of financing and funding options for the current year which, if successful, would provide the Company with capital to further the work programmes on the above noted projects.




Directors and Staff





I would like to thank my fellow directors, staff and consultants for their support and dedication, which has allowed the Company to continue to develop. Their support and commitment is key to the success of the Company.






Outlook






The Company is looking forward to the progressing of work programmes on its highly prospective Nickel, Copper and Platinum Group Element targets in Northern Ireland (including a tangible Copper target).   A clear work programme and strategy have been identified for the Company’s exploration assets in Finland and the Company is also hopeful of arriving at the end of the permitting process for the Lahtojoki diamond deposit which will enable the Company to progress to mine development on securing of appropriate finance. 





Finally, I would like to take this opportunity to place on record my appreciation for the continued support shown by both current and former directors in terms of remuneration deferral.  This is a significant number in the context of the Company’s balance sheet and consideration is currently being given to a potential re-structuring of these amounts.





Yours faithfully,





Brendan McMorrow
Chairman






26 February 2026





Karelian Diamond Resources plc




Condensed income statement and condensed statement of comprehensive income






for the six-month period ended 30 November 2025




 





Condensed income statement






Note







Six-month








period ended 30 November 2025








(Unaudited) €







Six-month period ended 30 November 2024




(Unaudited) €





Year ended 31 May 2025




(Audited) €








Continuing operations










Operating expenses








(180,623)





(164,741)



(364,615)






Movement in fair value of warrants







6






18,272





46,795



91,738







Operating loss









(162,351)





(117,946)



(272,887)






Interest expense








(3,240)





(3,240)




(6,480)








Loss before taxation









(165,591)





(121,186)



(279,357)







Income tax expense










–






–



–







Loss for the financial period/year









(165,591)





(121,186)



(279,357)








Loss per share









Basic and diluted loss per share





2






(0.0009)





(0.0012)



(0.0020)







Condensed statement of comprehensive income









Six-month period ended 30 November 2025






(Unaudited) €






Six-month period ended 30 November 2024




(Unaudited) €





Year ended 31 May 2025




(Audited) €








Loss for the financial period/year









(165,591)





(121,186)



(279,357)






Income/(expense) recognised in other comprehensive income








–






–




–







Total comprehensive income/(expense) for the financial period/year









(165,591)





(121,186)



(279,357)





Karelian Diamond Resources plc





Condensed statement of financial position








as at 30 November 2025








The accompanying notes form an integral part of these condensed financial statements.








Note








30 November 2025 (Unaudited)






30 November 2024 (Unaudited)





Year ended 31 May 2025 (Audited)






€






€





€








Assets











Non-current assets










Intangible assets







3






12,192,618





11,896,405



12,085,967






Tangible Assets








2,114





–



2,114







Total non-current assets









12,194,732





11,896,405



12,088,081







Current assets










Cash and cash equivalents








27,711





47,290



40,862






Other receivables








109,644





114,183



117,094







Total current assets









137,355





161,473



157,956







Total assets









12,332,087





12,057,878



12,246,037







Equity











Capital and reserves










Called up share capital presented as equity








3,226,368





3,209,432



3,220,201






Share premium








11,601,317





11,104,265



11,399,829






Share based payments reserve








450,658





450,658



450,658






Retained losses








(5,094,418)





(4,770,656)



(4,928,827)







Total equity









10,183,925





9,993,699



10,141,861







Liabilities











Non-current liabilities










Warrant liabilities







5






14,608





–



32,880







Total non-current liabilities









14,608





–



32,880







Current liabilities










Trade and other payables: amounts falling due within one year







6






1,987,808





1,902,683



1,928,790






Convertible Loan








135,442





128,962



132,202






Warrant Liabilities







5






–





4,230



–






Derivative Liability







5






10,304





10,304



10,304







Total current liabilities









2,133,554





2,064,179



2,071,296







Total liabilities









2,148,162





2,064,179



2,104,176







Total equity and liabilities









12,332,087





12,057,878



12,246,037





The accompanying notes form an integral part of these condensed financial statements.

Karelian Diamond Resources plc





Condensed statement of cash flows








for the six-month period ended 30 November 2025








Six-month period ended 30 November 2024 (Unaudited) €






Six-month period ended 30 November 2024 (Unaudited) €





Year ended 31 May 2025 (Audited)





€








Cash flows from operating activities










Loss for the financial period/year








(165,591)





(121,186)



(279,357)







Adjustments for:










Interest expense








3,240





3,240



6,480






Movement in fair value of warrants








(18,272)





(46,795)



(91,738)






Increase in trade and other payables








59,018





17,083



25,189






Decrease/(increase) in other receivables








7,450





(32,632)



(35,543)







Net cash used in operating activities









(114,155)





(180,290)



(374,969)







Cash flows from investing activities










Investment in exploration and evaluation








(106,651)





(206,211)



(395,773)






Expenditure on tangible assets








–





–



(2,114)







Net cash used in investing activities









(106,651)





(206,211)



(397,887)







Cash flows from financing activities










Proceeds on issue of share capital








207,655





394,194



774,121







Net cash provided by financing activities









207,655





394,194



774,121







Increase in cash and cash equivalents









(13,151)





7,693



1,265







Cash and cash equivalents at beginning of financial period/year










40,862






39,597




39,597








Cash and cash equivalents at end of financial period/year









27,711





47,290



40,862




Karelian Diamond Resources plc




Condensed statement of changes in equity










for the six-month period ended 30 November 2025









The accompanying notes form an integral part of these condensed financial statements.








Share capital (including deferred share capital)










Share premium










Share-based payment reserve









Retained








losses









Total equity









€









€









€









€









€









Balance at 1 June 2025








3,220,201







11,399,829







450,658







(4,928,827)







10,141,861







Issue of share capital








6,167









210,987









–









–









217,154








Share issue costs








–









(9,499)









–









–









(9,499)








Loss for the financial period








–









–









–









(165,591)









(165,591)









Balance at 30 November 2025









3,226,368









11,601,317









450,658









(5,094,418)









10,183,925









Balance at 1 June 2024








3,203,532







10,736,889







450,658







(4,649,470)







9,741,609







Issue of share capital






5,900





403,277





–





–





409,177






Share issue costs






–





(35,900)





–





–





(35,900)






Loss for the financial period






–





–





–





(121,187)





(121,187)







Balance at 30 November 2024








3,209,432







11,104,266







450,658







(4,770,657)







9,993,699









Share capital










The share capital comprises the nominal value share capital issued for cash and non-cash consideration. The share capital also comprises deferred share capital. The deferred share capital* arose through the restructuring of share capital which was approved at an Annual General Meeting held on 9 December 2016.










Authorised share capital:











The authorised share




capital at 30 November 2025 compromised 7,301,301,041 ordinary shares of €0.00025 each, and 317,785,034 deferred shares of €0.00999 each* (€5,000,000), (30 November 2024: 7,301,301,041 ordinary shares of €0.00025 each, and 317,785,034 deferred shares of €0.00999 each* (€5,000,000)).













*







Capital reorganisation:











Following approval at an Annual General Meeting (“AGM”) held on 9 December 2016, the Company reorganised its share capital by subdividing and reclassifying each issued ordinary share of €0.01 as one ordinary share of €0.00001 each and one deferred share of €0.00999 each.  The Deferred Shares have no right to vote, attend or speak at general meetings of the Company and have no right to receive any dividend or other distribution, and have only limited rights to participate in any return of capital on a winding-up or liquidation of the Company, which will be of no material value. No application was made to the London Stock Exchange for admission of the Deferred Shares to trading on the AIM.










Consolidated shares:










On 21 December 2017, the Company passed a Special Resolution at the Company’s AGM, that all of the ordinary shares of €0.00001 each in the capital of the Company, whether issued or unissued were consolidated into New Ordinary Shares of €0.00025 each in the capital of the Company (“consolidated shares”) on the basis of one consolidated share for every 25 existing ordinary shares. Following the consolidation of the ordinary shares on 21 December 2017, the warrants in issue were consolidated into one consolidated warrant for every 25 existing warrants. The exercise price in relation to the warrants was also adjusted at this time (see Note 2).










Share and Warrant issues during the period:











During the




period ended 30 November 2025, the Company raised €217,154 (£185,000) before expenses through the issue of 24,666,666 new ordinary shares at a price of £0.0075 per ordinary




share.











Share premium










The share premium comprises the excess consideration received in respect of share capital over the nominal value of the shares issued as adjusted for the costs of share issue in line with the Company’s accounting policies.










Share based payment reserve










The share based payment reserve comprises of the fair value of all share options and warrants which have been charged over the vesting period, net of amounts relating to share options and warrants forfeited, exercised or lapsed during the period, which are reclassified to retained earnings.










Retained losses










This reserve represents the accumulated losses incurred by the Company up to the condensed statement of financial position date.








The accompanying notes form an integral part of these condensed financial statements.

Karelian Diamond Resources plc





Notes
to and forming part of the condensed financial statements for the six-month period ended 30 November 2025






Accounting policies







1. Reporting entity






Karelian Diamond Resources plc (the “Company”) is a company domiciled in Ireland.






Basis of preparation and statement of compliance






The condensed financial statements for the six months ended 30 November 2025 are unaudited.





The condensed financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34: Interim Financial Reporting.





The condensed financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company’s annual financial statements as at 31 May 2025, which are available on the Company’s website – www.kareliandiamondresources.com. The accounting policies adopted in the presentation of the condensed financial statements are consistent with those followed in the preparation of the Company’s annual financial statements for the year ended 31 May 2025.





The condensed financial statements have been prepared under the historical cost convention, except for derivative financial instruments which are measured at fair value at each reporting date.





The condensed financial statements are presented in Euro (“€”). The Euro is the functional currency of the Company.





The preparation of condensed financial statements requires the Board of Directors and management to use judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. Actual results may differ from those estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the financial period in which the estimate is revised and in any future financial periods affected. Details of critical judgements are disclosed in the accounting policies detailed in the annual financial statements.





The financial information presented herein does not amount to statutory financial statements that are required by Chapter 4 part 6 of the Companies Act 2014 to be annexed to the annual return of the Company. The statutory financial statements for the financial year ended 31 May 2025 were annexed to the annual return and filed with the Registrar of Companies. The audit report on those financial statements was unqualified.





These condensed financial statements were authorised for issue by the Board of Directors on 26 February 2026.





Going concern




The Company recorded a loss of € 165,591 for the six-month period ended 30 November 2025 (30 November 2024: loss of €121,186). The Company had net current liabilities of €1,996,197 at that date (30 November 2024: €1,902,276).




The Board of Directors have considered carefully the financial position of the Company and in that context, have prepared and reviewed cash flow forecasts for the period to 28 February 2027. As set out further in the Chairman’s statement, the Company expects to incur capital expenditure in 2026, consistent with its strategy as an exploration company. In reviewing the proposed work programme for exploration and evaluation assets, the results obtained from the exploration programme and the prospects for raising additional funds as required, the Board of Directors are satisfied that it is appropriate to prepare the financial statements on a going concern basis.






Statement of compliance






The Company’s financial statements have been prepared in accordance with IFRS as adopted by the European Union (“EU”).






Recent accounting pronouncements





Certain new accounting standards and interpretations have been published and endorsed by the EU that were not mandatory for 31 May 2025 reporting periods and have not been early adopted by the Company.  Directors do not consider that those of the below that will be effective for the year ended 31 May 2026 will have a material effect on the financial statements and they are considering whether or not those that become effective in the following financial year will have any impact on the financial statements.






  • Amendments to IAS 21 Lack of Exchangeability – Effective date 1 January 2025;









  • Amendments to IAS 7 and IFRS 17 regarding supplier finance arrangements – Effective date 1 January 2025;









  • Amendments to IFRS 9 and IFRS 7 regarding classification and measurement of financial instruments – Effective date 1 January 2026;









  • Annual Improvements to IFRS Accounting Standards – Volume 11 – Effective date 1 January 2026;








  1. Profit/(loss) per share






Basic earnings per share






Six-month period ended 30 November 2025 (Unaudited) €










Six-month period ended 30 November 2024 (Unaudited) €









Year ended 31 May 2025




(Audited)
€








Loss for the financial period/year attributable to equity holders of the Company









(165,591)





(121,186)



(279,357)






Number of ordinary shares for the purposes of earnings per share








182,784,936





124,748,635



138,390,187







Basic loss per ordinary share









(€0.0009)





(€0.0012)



(€0.0020)





Diluted earnings/(loss) per share






The effect of share options and warrants is anti-dilutive.






  1. Intangible assets







Exploration and evaluation assets









Cost









30 November 2025 (Unaudited) €






30 November 2024 (Unaudited) €





31 May 2025




(Audited) €








At 1 June









12,085,967





11,690,194



11,690,194






Expenditure during the financial period/year









  • License and appraisal costs








59,885





118,372



199,937






  • Other operating expenses








46,766





87,839



195,836







At 30 November/31 May









12,192,618





11,896,405



12,085,967







Exploration and evaluation assets relate to expenditure incurred in the development of mineral exploration opportunities. These assets are carried at historical cost and have been assessed for impairment in particular with regard to the requirements of IFRS 6: Exploration for and Evaluation of Mineral Resources relating to remaining licence or claim terms, likelihood of renewal, likelihood of further expenditure, possible discontinuation of activities as a result of specific claims and available data which may suggest that the recoverable value of an exploration and evaluation asset is less than its carrying amount. 











The Board of Directors have considered the proposed work programmes for the underlying mineral resources. They are satisfied that there are no indications of impairment.











The Board of Directors note that the realisation of the intangible assets is dependent on further successful development and ultimate production of the mineral resources and the availability of sufficient finance to bring the resources to economic maturity and profitability.











  1. Commitments and Contingencies








At 30 November 2025, there were no capital commitments or contingent liabilities (31 May 2025: No capital commitments or contingencies liabilities). Should the Company decide to develop the Lahtojoki project, an amount of €40,000 is payable by the Company to the vendors of the Lahtojoki mining concession.






  1. Convertible Loan






On 26 May 2023, the Company entered into a convertible loan note agreement for a total amount of €129,550 (£112,500) with Conroy Gold and Natural Resources plc which is both a shareholder in the company and has a number of other connections as set out in Note 14 to the audited financial statements for year ended 31 May 2025. The convertible loan note is unsecured, had a term of 18 months and attracts interest at a rate of 5% per annum which is payable on the maturity or conversion of the convertible loan. The conversion price is at a price of 5 pence per ordinary share. The shareholder has the right to seek conversion of the principal amount outstanding on the convertible loan note and all interest accrued at any time during the term.   The convertible term has passed but the loan continues in place on an informal basis on the same terms and is classified as a current liability for the period ended 30 November 2025.  The Company is in discussions with the note holder to extend the term of the loan note.





€10,304 was recorded as a derivative liability attached to the total convertible loan note above and the net amount of €119,246 was initially recorded as the value of the convertible loan at 31 May 2023. The loan incurred interest of €3,240 in the current period (31 November 2024: €3,240).






  1. Trade and other payables: amounts falling due within one year






Included in the payables figure of €1,987,806 is an amount of €1,660,704 in respect of amounts owing to both current and former directors of the Company who provide continuing support to the Company through renewing annually a commitment not to seek payment of the amounts owed unless the Company is in a position to discharge them.






  1. Warrant liabilities






The Company holds Sterling based warrants. The Company estimates the fair value of the sterling-based warrants using the Binomial Lattice Model. The determination of the fair value of the warrants is affected by the Company’s share price along with other assumptions.





As part of the share issue in July 2024, the Company issued 11,799,997 warrants at a price of GBP 3 pence per warrant.   These warrants expired in July 2025.   There are 43,076,667 warrants to acquire shares at a price of GBP 1.5p per share still in issue, expiring in February 2027. The fair value of these warrants was €14,607 as at 30 November 2025.   The movement in fair value of warrants including the effect of warrant expiry resulted in a non-cash gain of €18,272 in the period.






  1. Related party transactions





  1. Apart from Directors’ remuneration, equity investment from Directors, and loans from shareholders, (who are also Directors), there have been no contracts or arrangements entered into during the six-month period in which a Director of the Company had a material interest.



  1. The Company shares accommodation and staff with Conroy Gold and Natural Resources plc (“Conroy”) which have certain common Directors and shareholders. For the six-month period ended 30 November 2025, Conroy incurred costs totalling €38,756 (30 November 2024: €34,245) on behalf of the Company.  These costs were recharged to the Company by Conroy.  At 30 November 2025, Conroy was owed €115,031 (30 November 2024: €126,592) by the Company.





  1. Subsequent events






There were no other material events subsequent to the reporting date which necessitate revision of the figures or disclosures included in the financial statements.  






  1. Approval of the condensed financial statements






These condensed financial statements were approved by the Board of Directors on 26 February 2026.  A copy of the condensed financial statements will be available on the Company’s website www.kareliandiamondresources.com on 27 February 2026.






Karelian

Cision PR Newswire

Cision PR Newswire

Related Posts

Childhelp Co-Founder Sara O’Meara to Receive Lifetime Achievement Award from Place of Hope

February 27, 2026

Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies with CBC and CBD

February 27, 2026

TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

February 27, 2026

Healthcare Triangle Subsidiary QuantumNexis Inc. Launches its Dubai, UAE Operations to accelerate Digital Health Transformation across the GCC Countries

February 27, 2026

IsoEnergy Highlights Strong Jurisdictional Rankings in the Fraser Institute’s 2026 Annual Survey of Mining Companies and Files Fiscal 2025 Annual Report

February 27, 2026

Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome

February 27, 2026

Popular News

  • Childhelp Co-Founder Sara O’Meara to Receive Lifetime Achievement Award from Place of Hope

    0 shares
    Share 0 Tweet 0
  • TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

    0 shares
    Share 0 Tweet 0
  • Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies with CBC and CBD

    0 shares
    Share 0 Tweet 0
  • Healthcare Triangle Subsidiary QuantumNexis Inc. Launches its Dubai, UAE Operations to accelerate Digital Health Transformation across the GCC Countries

    0 shares
    Share 0 Tweet 0
  • DeFi Technologies Appoints Philippe Lucet as General Counsel and Corporate Secretary

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home
  • Business

© 2025 World Lifestyler